Core Viewpoint - Mingfa Group (00846) has experienced a significant decline in revenue and has reported a loss for the first half of the fiscal year ending June 30, 2025, indicating potential challenges in its financial performance [1] Group 1: Shareholder Activity - On October 10, shareholders of Mingfa Group transferred shares from Haitong International Securities to DBS Bank, with a total market value of HKD 164 million, representing 16.41% of the company's shares [1] Group 2: Financial Performance - For the six months ending June 30, 2025, Mingfa Group reported revenue of HKD 2.726 billion, a decrease of 28.6% year-on-year [1] - The company recorded a loss attributable to equity holders of HKD 273 million, compared to a profit of HKD 6.7 million in the same period last year [1] - The loss per share was reported at HKD 0.045 [1]

Core Insights - The sales performance of gold and jewelry stores during the 2025 Golden Week exceeded expectations, primarily driven by strong consumer spending in economically developed regions such as the Yangtze River Delta and parts of Anhui and Shandong [1][3] - Among the major brands, Chao Hong Ji showed the most significant growth at approximately 30%, while Lao Feng Xiang and China Gold maintained steady growth at around 15%, and Chow Tai Fook experienced moderate growth of about 5% [1][3] Group 1 - The 2025 Golden Week sales were primarily concentrated in economically developed areas, leading to higher consumer spending and acceptance of fixed-price gold jewelry [1][3] - Chao Hong Ji's innovative design and flexible marketing strategies contributed to its leading growth among the four major brands [3][4] - The overall sales during the Golden Week saw a positive year-on-year growth, with an increase in average transaction value being the main driver [1][3] Group 2 - The proportion of fixed-price products is increasing across brands to balance profit pressures and optimize profit structures, with Chao Hong Ji having about 60-70% of its products at fixed prices [4] - Chow Tai Fook is transitioning from a weight-based product strategy to a profit-oriented approach, planning to close around 10 underperforming stores while enhancing its fixed-price product offerings [4][5] - Chao Hong Ji plans to continue its expansion with an expected addition of 10-20 new stores, focusing on shopping centers and younger consumers [4][5] Group 3 - There are significant differences in single-store sales volumes among brands, with Lao Feng Xiang leading at approximately 18 million, followed by Chow Tai Fook at over 15 million [5] - Chao Hong Ji employs a refined replenishment mechanism based on sales data from its top 50 franchisees, resulting in higher inventory turnover efficiency [5] - The inventory management strategies vary, with Chow Tai Fook primarily using a consignment model, while Lao Feng Xiang and China Gold follow more traditional models [5] Group 4 - The sales performance in the first three quarters of 2025 showed a fluctuation of approximately 10%/-5%/15%, indicating a structural divergence in brand performance [6] - The industry is expected to continue experiencing structural differentiation, with Chao Hong Ji accelerating its expansion and Chow Tai Fook focusing on profit recovery and structural optimization [6] - Future competition in the industry will likely center on product innovation, brand rejuvenation, and improving channel efficiency [6]

智通财经APP获悉，海通国际发布研报称，据预测，25年9月重点跟踪的8个必选消费行业中5个保持正 增长，3个负增长。个位数增长的行业包括速冻食品、软饮料、调味品、啤酒和餐饮；下降的行业包括 次高端及以上白酒、大众及以下白酒和乳制品。与上月相比，5个行业增速改善，3个变差。双节前消费 和备货意愿不强，节后统计数据也显示商品消费弱于服务消费(国家税务总局数据显示增速分别为3.9% 和7.6%，整体增速4.5%)。 乳制品：9月国内乳制品行业收入为455亿元，同比下滑4.6%。1-9月累计收入为3531亿元，同比下滑 1.2%。乳制品需求仍然承压，礼赠市场表现不佳，经销商中秋国庆双节备货意愿谨慎。同时我们在九 月价格月报中也观察到乳制品线上零售价折扣率再次加大，价格竞争现象仍然较多。 速冻食品：9月国内速冻行业收入为78亿元，同比增长4.0%，1-9月累计收入805亿元，同比增长1.7%。 3Q25速冻食品需求整体表现平稳，9月为迎接双节，餐饮渠道纷纷备货，从而拉动对速冻食品的需求增 长，环比需求出现改善。进入下半年高基数影响逐渐消化。龙头企业各自调整策略争取全年增长。 软饮料：9月国内软饮料行业收入为663亿元， ...

【海通国际：首次覆盖金沙中国并给予优于大市评级】智通财经10月8日电，海通国际10月5日就金沙中 国有限公司(01928.HK)发布研报称，作为澳门博彩龙头，在行业复苏的背景下，进入"盈利能力提升-现 金流质量改善-分红稳定"的正向循环，当前估值仍低于疫情前水平。首次覆盖该公司并给予"优于大 市"评级，目标价25.6港元。 转自：智通财经 ...

海通国际发布研报称，金沙中国作为澳门博彩龙头，在行业复苏的背景下，进入"盈利能力提升-现金流 质量改善-分红稳定"的正向循环，当前估值仍低于疫情前水平。该行首次覆盖该公司并给予"优于大 市"评级，目标价25.6港元。 ...

海通国际预计金沙中国2025至2027年各年收入分别为73.95亿、79.07亿及83.25亿美元，同比增长4.4%、 6.9%及5.3%，博彩毛收入为70.34亿、74.71亿及78.64亿美元，同比增长4.3%、6.2%及5.3%，经调整物 业EBITDA为24.17亿、26.52亿及28.41亿美元，经调整物业EBITDA利润率为32.7%、33.5%及34.1%。 海通国际发布研报称，首次覆盖金沙中国(01928)，予"优于大市"评级，目标价25.6港元。作为澳门博彩 龙头，在行业复苏的背景下，金沙中国进入盈利能力提升-现金流质量改善-分红稳定的正向循环，当前 估值仍低于疫情前水平。金沙中国共有约1,680张赌台、约3,700台角子机，为澳门六家上市博企之最。 除了受到最大赌台规模的正向影响之外，公司庞大的中场业务基础使其在行业覆苏及游客回流时最先受 益。 报告指，金沙中国专注中场业务，定位中高端客户，中场高赢率为公司带来更多的利润，叠加规模最大 的赌台及老虎机数量，使得公司的市场份额多年蝉联第一。此外，澳门伦敦人已于第二季改造完成，其 经调整EBITDA利润率已回升至31.9%，后续有望持续改善并带 ...

海通国际预计金沙中国2025至2027年各年收入分别为73.95亿、79.07亿及83.25亿美元，同比增长4.4%、 6.9%及5.3%，博彩毛收入为70.34亿、74.71亿及78.64亿美元，同比增长4.3%、6.2%及5.3%，经调整物 业EBITDA为24.17亿、26.52亿及28.41亿美元，经调整物业EBITDA利润率为32.7%、33.5%及34.1%。 智通财经APP获悉，海通国际发布研报称，首次覆盖金沙中国(01928)，予"优于大市"评级，目标价25.6 港元。作为澳门博彩龙头，在行业复苏的背景下，金沙中国进入盈利能力提升-现金流质量改善-分红稳 定的正向循环，当前估值仍低于疫情前水平。金沙中国共有约1,680张赌台、约3,700台角子机，为澳门 六家上市博企之最。除了受到最大赌台规模的正向影响之外，公司庞大的中场业务基础使其在行业覆苏 及游客回流时最先受益。 报告指，金沙中国专注中场业务，定位中高端客户，中场高赢率为公司带来更多的利润，叠加规模最大 的赌台及老虎机数量，使得公司的市场份额多年蝉联第一。此外，澳门伦敦人已于第二季改造完成，其 经调整EBITDA利润率已回升至31.9%， ...

Core Viewpoint - Jingyin Pharmaceutical is a global clinical-stage biotechnology company focused on developing siRNA therapies and has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs, Haitong International, and HSBC as joint sponsors [1] Industry Summary - The siRNA therapy market is projected to grow from $2.4 billion in 2024 to $50.3 billion by 2040, representing a compound annual growth rate (CAGR) of 20.9% [1] - siRNA therapies address disease mechanisms at the nucleic acid level and can target "undruggable" proteins that traditional technologies struggle to reach, offering a paradigm shift in chronic disease management with advantages such as longer durability, higher compliance, good safety profile, and lower drug interactions [1] Company Summary - The company has three core product pipelines focusing on coagulation disorders, cardiovascular metabolic diseases, and obesity [1] - SRSD107 is a potential first-in-class siRNA drug targeting coagulation factor XI, currently undergoing Phase II clinical trials in Europe [1] - SRSD216 is a potential best-in-class siRNA targeting Lp(a), with ongoing Phase IIa trials in China and the United States [1] - SRSD384 is an INHBE-targeting candidate drug for obesity, supported by compelling preclinical data, and is actively pursuing IND application [1] - The company’s proprietary PEPR platform includes chemical modifications, target and sequence optimization, and delivery technologies, and is researching extrahepatic delivery systems to expand the range of siRNA effects [1]

Group 1 - Baidu's stock in Hong Kong rose over 3%, leading to a pre-market increase of over 3% for its US shares [1] - Haitong International upgraded Baidu's valuation method from Price-to-Earnings (PE) to Sum-of-the-Parts (SoTP) due to the new CFO's strategy to "unlock hidden assets" [1] - Baidu is reshaping its traditional business in the wake of the large language model (LLM) trend and aims to surpass competitors in the cloud market through various measures [1] Group 2 - Specific measures include adjusting traditional search operations, enriching AI SaaS products, providing cost-effective and reliable cloud infrastructure, and building an open foundational model ecosystem [1] - The valuation adjustment considers a 45% discount, resulting in a total market value of $64 billion, or a target price of $188 per ADR, corresponding to a projected 22x PE for fiscal year 2025 [1]

该行上调对百度的估值，考虑综合企业45%折让，得出总市值640亿美元，或每股ADR目标价188美元， 该目标价对应百度预测2025财年22倍市盈率。在牛市情境中，假设相反的情况，得出每股ADR目标价 246美元，对应预测2025财年29倍市盈率，维持"优于大市"评级。 海通国际发表研究报告指，将百度估值方法从市盈率(PE)改为分部估值法(SoTP)，因新任首席财务官提 出的"释放隐藏资产"策略，包括在大语言模型(LLM)浪潮下，百度正重新塑造其传统业务，并寻求在云 端市场超越竞争对手的机会，具体措施包括调整传统搜寻业务；丰富AI SaaS产品；提供具成本效益且 高可靠性的云端基础设施；致力于打造开放的基础模型生态系统。 ...